Case Studie
The Strategic Advisory Group of Experts on Immunization (SAGE) plays a central role in shaping global vaccine policy that shape national immunization strategies worldwide.
MMGH has supported SAGE’s work by translating evidence into clear, actionable recommendations that guide the introduction and use of vaccines across countries and regions.
To date we have supported the policy recommendations on Dengue (2022-23), Pneumoccocal Conjugate Vaccines (2023-25), Respiratory Syncytial Virus (2024) and Typhoid Conjugate Vaccines (2024-25).
As a long-standing technical partner, MMGH supports SAGE and its working groups by coordinating inputs across stakeholders, synthesizing evidence, and facilitating transparent decision-making processes. Our work strengthens the quality and usability of global immunization policy recommendations.
Provided support, and facilitation to the SAGE Secretariat and working groups.
Synthesized complex data and evidence into clear policy options and recommendations using the GRADE and Evidence-to-Recommendations frameworks.
Supported coordination between WHO departments, external experts, and partners across the immunization landscape.
Reviewed and drafted policy documents for vaccine introductions and schedule changes.
Our work has helped streamline SAGE’s policy development processes and ensured that recommendations are grounded in both technical evidence and implementation realities—contributing to timely and effective policy adoption globally.
To find out how we can assist with your upcoming projects, please fill in this form and someone from our team will contact you shortly.